TRPS1 expression in breast carcinoma and its relationship with Er, Pr, Her2 neu and other clinicopathological parameters
Background : TRPS1 is a transcription factor with prominent expression in mammary epithelial cells and has attracted interest as a potential biomarker in breast carcinoma. This study assessed TRPS1 immunoreactivity and examined its relationship with hormone-receptor status and selected clinicopathological characteristics. Materials and Methods : A hospital-based cross-sectional observational study was undertaken in the Department of Pathology, Sri Guru Ramdas Institute of Medical Sciences and Research, from July 2024 through December 2025. Fifty-two histologically confirmed breast carcinoma cases represented by mastectomy specimens were evaluated. Immunohistochemical staining for TRPS1, ER, PR and HER2neu was performed on formalin-fixed, paraffin-embedded tissue. Associations between categorical variables were assessed with the chi-square test or Fisher's exact test, with statistical significance defined as p≤0.05. Results : The patients had a mean age of 54.44 years, with ages ranging from 29 to 80 years. Tumors measuring 2–5 cm constituted 71.2% of cases, while 61.5% were histological grade III. ER, PR and HER2neu positivity were identified in 42.3%, 32.7% and 26.9% of cases, respectively. TRPS1 was positive in 44 of 52 cases (84.6%). TRPS1 expression showed significant relationships with histological grade (p=0.015), lymphovascular invasion (p=0.042), ER status (p=0.008), PR status (p=0.032), and combined ER/PR status (p=0.031). No statistically significant relationship was demonstrated with HER2 neu, age, tumor size or lymph-node status. Conclusion : In this cohort, TRPS1 expression was frequent and was associated particularly with hormone-receptor positivity and lower tumor grade. TRPS1 may therefore have value as an adjunctive marker in the assessment of breast carcinoma, although larger studies with longer follow-up are required.
Authors
- Menka Khanna
- Karamjit S. Gill
- Tanvir Kaur Saini
- Ishaan Khanna
- Arpanpreet Kaur Bhinder
Publication Details
- Journal
- Indian Journal of Pathology and Oncology
- Published
- 2026-11-16
- DOI
- https://doi.org/10.18231/j.ijpo.18588.1793256300
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00